Seminars in Oncology
Volume 33, Supplement 3 , Pages 33-36, February 2006

Future Perspectives in the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

  • Reinhard Dummer

      Affiliations

    • Corresponding Author InformationAddress correspondence and reprint requests to Reinhard Dummer, MD, Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH−8091 Zürich

Department of Dermatology, University Hospital of Zurich, Switzerland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This supplement was supported by an unrestricted educational grant from Zeneus Pharma Ltd.

 Prof Dummer has participated in scientific symposia and advisory boards sponsored by Zeneus and Ligand Pharma.

PII: S0093-7754(05)00515-4

doi:10.1053/j.seminoncol.2005.12.021

Seminars in Oncology
Volume 33, Supplement 3 , Pages 33-36, February 2006

Article Tools

* Image Usage & Resolution